+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarkers Global Market Report 2022

  • PDF Icon

    Report

  • 175 Pages
  • August 2022
  • Region: Global
  • The Business Research Company
  • ID: 5640964
Major players in the biomarkers market are Enzo Biochem Inc, Bio-Rad Laboratories Inc, Merck KGaA, PerkinElmer Inc, QIAGEN, Epigenomics AG, F Hoffmann-La Roche Ltd, Abbott, Meso Scale Diagnostics LLC, EKF Diagnostics Holdings plc, GE Healthcare, Agilent Technologies Inc, Johnson & Johnson Services Inc, Siemens and Thermo Fisher Scientific Inc.

The global biomarkers market is expected to grow from $47.72 billion in 2021 to $54.22 billion in 2022 at a compound annual growth rate (CAGR) of 13.62%. The biomarkers market is expected to reach $89.86 billion in 2026 at a CAGR of 13.46%.

The biomarkers market consists of sales of biomarkers by entities (organizations, partnerships, and sole proprietors) that refer to a molecular marker, which is used to check the body responds to a treatment for a disease or condition. It is a biological molecule found in blood, body fluids, and tissues that show signs of a normal or abnormal process of a disease. These biomarkers have a clinical role in narrowing or guiding treatment decisions.

The main types of biomarkers are biomarker of exposure and biomarker of diseases. The biomarker of exposure is a substance corresponding to the chemical that may be found in the body. When a person is exposed to chemicals by direct contact, inhaling or ingesting helps to identify them. Various technologies used for biomarker are safety biomarkers, efficacy biomarkers and validation biomarkers used to treat diseases such as neurological diseases, cancer, immunological diseases, cardiovascular diseases and other. These biomarker are used by pharmaceutical companies, government and private research institutes, academic institutes and medical device manufacturing companies for risk assessment, development of molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic application and others (DNA fingerprinting and others).

North America was the largest region in the biomarkers market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The biomarkers market research report is one of a series of new reports that provides biomarkers market statistics, including biomarkers industry global market size, regional shares, competitors with a biomarkers market share, detailed biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the biomarkers industry. This biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increase in heart diseases is expected to propel the growth of the biomarkers market in the forecasted period. The use of biomarkers for heart disease patients has increased tremendously over the last few years. Currently, the natriuretic peptides are the most used biomarker and help in the diagnosis of patients with heart failure. Biomarkers such as circulating biomarkers with high sensitivity C-reactive protein are used for the diagnosis of heart failure. Heart disease is among leading cause of death for people of most racial and ethnic groups in the United States. The increase in heart diseases will drive the demand for biomarkers. For instance, in March 2021, according to National Center for Health Statistics (NCHS) and National Vital Statistics System (NVSS), there has been a substantial increase in heart diseases from 2019 to 2020. Heart disease deaths increased by 4.8% in the US in 2020, the largest increase in heart disease deaths since 2012. In the US, nearly 6,908,820 people died in 2020 of heart disease. Because of the increase in heart diseases and heart deaths, there will be an increase in growth for the biomarkers.

Rise in new agreements between the companies is the key trend gaining popularity in the biomarkers market. Major companies operating in the biomarkers market are focused on making agreements with other players to develop and launch new solutions and strengthen their position. For instance, in July 2020, Thermo Fisher Scientific, a US-based analytical laboratory instrument manufacturing company signed a companion diagnostic (CDx) agreement with a Japan-based pharmaceutical company Chugai Pharmaceutical. This agreement helps to expand the use of the Oncomine Dx Target Test and expedite local biomarker testing of non-small cell lung cancer (NSCLC) patients eligible for Rozlytrek (entrectinib) treatment in Japan. In addition, in September 2020, Thermo Fisher Scientific announced new collaborations among the Thermo Fisher Precision Medicine Science Center, AstraZeneca (a UK-based pharmaceutical and biotechnology company), and the University of Nebraska Medical Center for clinical biomarker discovery. This collaboration intends to create standardized workflows with pharma and academic partners to streamline the transition from biomarker research to clinical implementation.

In October 2020, Medidata, a US-based company and a subsidiary of Dassault Systèmes, offering end-to-end solutions to support clinical development process, acquired the digital biomarker business of MC10. Through this acquisition, Medidata will integrate offering that will help healthcare and medical devices companies to get better understanding of diseases, novel endpoints, and transformational therapies. MC10 is a US-based company focused on improving human health through digital solutions.
The countries covered in the biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.




This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Biomarkers Market Characteristics3. Biomarkers Market Trends And Strategies4. Impact Of COVID-19 On Biomarkers
5. Biomarkers Market Size And Growth
5.1. Global Biomarkers Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Biomarkers Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Biomarkers Market Segmentation
6.1. Global Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers
6.2. Global Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Neurological Diseases
  • Cancer
  • Immunological Diseases
  • Cardiovascular Diseases
  • Other
6.3. Global Biomarkers Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Biomarker Of Exposure
  • Biomarker Of Diseases
6.4. Global Biomarkers Market, Segmentation By Audiences, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Companies
  • Government And Private Research Institutes
  • Academic Institutes
  • Medical Device Manufacturing Companies
6.5. Global Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Risk Assessment
  • Development of Molecular Diagnostic
  • Disease Diagnosis
  • Drug Discovery And Development
  • Drug Formulation
  • Forensic Application
  • Others (DNA Fingerprinting And Others )
7. Biomarkers Market Regional And Country Analysis
7.1. Global Biomarkers Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Biomarkers Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Biomarkers Market
8.1. Asia-Pacific Biomarkers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Biomarkers Market
9.1. China Biomarkers Market Overview
9.2. China Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Biomarkers Market
10.1. India Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Biomarkers Market
11.1. Japan Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Biomarkers Market
12.1. Australia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Biomarkers Market
13.1. Indonesia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Biomarkers Market
14.1. South Korea Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Biomarkers Market
15.1. Western Europe Biomarkers Market Overview
15.2. Western Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Biomarkers Market
16.1. UK Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Biomarkers Market
17.1. Germany Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Biomarkers Market
18.1. France Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.2. France Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Biomarkers Market
19.1. Eastern Europe Biomarkers Market Overview
19.2. Eastern Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Biomarkers Market
20.1. Russia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Biomarkers Market
21.1. North America Biomarkers Market Overview
21.2. North America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Biomarkers Market
22.1. USA Biomarkers Market Overview
22.2. USA Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Biomarkers Market
23.1. South America Biomarkers Market Overview
23.2. South America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Biomarkers Market
24.1. Brazil Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Biomarkers Market
25.1. Middle East Biomarkers Market Overview
25.2. Middle East Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Biomarkers Market
26.1. Africa Biomarkers Market Overview
26.2. Africa Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Biomarkers Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Biomarkers Market Competitive Landscape And Company Profiles
27.1. Biomarkers Market Competitive Landscape
27.2. Biomarkers Market Company Profiles
27.2.1. Enzo Biochem Inc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bio-Rad Laboratories Inc
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Merck KGaA
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. PerkinElmer Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. QIAGEN
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Biomarkers Market29. Biomarkers Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer

Executive Summary

Biomarkers Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global biomarkers market.

This report focuses on biomarkers market which is experiencing strong growth. The report gives a guide to the biomarkers market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the biomarkers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biomarkers market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biomarkers market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biomarkers market section of the report gives context. It compares the biomarkers market with other segments of the biomarkers market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biomarkers indicators comparison.

Scope


Markets Covered:

1) By Technology: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers
2) By Disease: Neurological Diseases; Cancer; Immunological Diseases; Cardiovascular Diseases; Other
3) By Type: Biomarker Of Exposure; Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies; Government And Private Research Institutes; Academic Institutes; Medical Device Manufacturing Companies
5) By Application: Risk Assessment; Development of Molecular Diagnostic; Disease Diagnosis; Drug Discovery And Development; Drug Formulation; Forensic Application; Others (DNA Fingerprinting And Others)

Companies Mentioned: Enzo Biochem Inc.; Bio-Rad Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; QIAGEN

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Enzo Biochem Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN

Methodology

Loading
LOADING...